Cellular antiseizure mechanisms of everolimus in pediatric tuberous sclerosis complex, cortical dysplasia, and non–mTOR‐mediated etiologies

The present study was designed to examine the potential cellular antiseizure mechanisms of everolimus, a mechanistic target of rapamycin (mTOR) pathway blocker, in pediatric epilepsy cases. Cortical tissue samples obtained from pediatric patients (n = 11, ages 0.67–6.75 years) undergoing surgical re...

Descripción completa

Detalles Bibliográficos
Autores principales: Cepeda, Carlos, Levinson, Simon, Yazon, Vannah‐Wila, Barry, Joshua, Mathern, Gary W., Fallah, Aria, Vinters, Harry V., Levine, Michael S., Wu, Joyce Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Full‐length Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293070/
https://www.ncbi.nlm.nih.gov/pubmed/30564777
http://dx.doi.org/10.1002/epi4.12253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293070/
https://www.ncbi.nlm.nih.gov/pubmed/30564777
http://dx.doi.org/10.1002/epi4.12253

Ejemplares similares